Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-26

Clinical Trial Update: Randomized Trial Comparing Colesevelam vs. Ezetimibe [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing colesevelam versus ezetimibe in adults with type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colesevelam (colesevelam)
  • EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: LMC Diabetes & Endocrinology Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED